Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway.
Henkel PS, Burger EA, Sletner L, Pedersen K.
Med Decis Making. 2024 Apr 09. 272989X241241339. PMID: 38591188
Research Scientists
Emily Annika Burger
Links
Bibliography
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework.
Kunst N, Burger EA, Coupé VMH, Kuntz KM, Aas E.
Pharmacoeconomics. 2024 Apr. 42(4):363-371. PMID: 38157129
Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis.
Portnoy A, Pedersen K, Sy S, Tropé A, Engesaeter B, Kim JJ, Burger EA.
Int J Cancer. 2024 Mar 15. 154(6):1073-1081. PMID: 38088449
Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.
Spencer JC, Burger EA, Campos NG, Regan MC, Sy S, Kim JJ.
J Natl Cancer Inst Monogr. 2023 11 08. 2023(62):188-195. PMID: 37947333
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
Prem K, Choi YH, Bénard É, Burger EA, Hadley L, Laprise JF, Regan MC, Drolet M, Sy S, Abbas K, Portnoy A, Kim JJ, Brisson M, Jit M.
BMC Med. 2023 08 28. 21(1):313. PMID: 37635227
Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines.
Pedersen K, Kristiansen IS, Sy S, Kim JJ, Burger EA.
Value Health. 2023 08. 26(8):1217-1224. PMID: 37116697
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study.
Landy R, Haber G, Graubard BI, Campos NG, Sy S, Kim JJ, Burger EA, Cheung LC, Katki HA, Gillison ML, Chaturvedi AK.
J Natl Cancer Inst. 2023 04 11. 115(4):429-436. PMID: 36655795
The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trial.
Knauss T, Hansen BT, Pedersen K, Aasbø G, Kunst N, Burger EA.
Gynecol Oncol. 2023 01. 168:39-47. PMID: 36371904
A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions.
Burger EA, de Kok IMCM, O'Mahony JF, Rebolj M, Jansen EEL, de Bondt DD, Killen J, Hanley SJ, Castanon A, Regan MC, Kim JJ, Canfell K, Smith MA.
Elife. 2022 10 12. 11. PMID: 36222673
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective.
Hertzberg SNW, Jørstad ØK, Petrovski BÉ, Bragadottir R, Steffensen LA, Moe MC, Burger EA, Petrovski G.
Int J Environ Res Public Health. 2022 Oct 02. 19(19). PMID: 36231903